Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,470
datasets available to search
ShareScore release 0.9.0
Dataset results
2,470 results for “Acute Myeloid Leukemia”
A Phase I Dose Escalation Study of GSK2879552 in Subjects With Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT02177812. IPD Sharing: YES. Countries: 3. Publications: 0.
A Study Of Treatment Patterns And Clinical Outcomes In Patients Diagnosed With Acute Myeloid Leukemia Who Received Mylotarg in the Real-World
ClinicalTrials.gov study NCT04337138. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of MEN1112 Intravenous Infusion in Relapsed or Refractory Acute Myeloid Leukemia
ClinicalTrials.gov study NCT02353143. IPD Sharing: Not stated. Countries: 5. Publications: 0.
Standard Idarubicin and Cytarabine for the Treatment of Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT00422591. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Immunotherapy for Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Blast Phase Chronic Myelogenous Leukemia (BP CML), and Myelodysplastic Syndrome (MDS) Relapse After Allogeneic Trans
ClinicalTrials.gov study NCT00548847. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Chemosensitization With Plerixafor Plus G-CSF in Acute Myeloid Leukemia
ClinicalTrials.gov study NCT00906945. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Clofarabine and Daunorubicin in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia
ClinicalTrials.gov study NCT00814164. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Lestaurtinib, Cytarabine, and Idarubicin in Treating Younger Patients With Relapsed or Refractory Acute Myeloid Leukemia
ClinicalTrials.gov study NCT00469859. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Gilteritinib vs Midostaurin in FLT3 Mutated Acute Myeloid Leukemia
ClinicalTrials.gov study NCT03836209. IPD Sharing: NO. Countries: 1. Publications: 0.
Tipifarnib Versus Best Supportive Care in the Treatment of Newly Diagnosed Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT00093990. IPD Sharing: Not stated. Countries: 0. Publications: 1.
Azacitidine and Lenalidomide for Relapsed and Refractory Patients With Acute Myeloid Leukemia
ClinicalTrials.gov study NCT01743859. IPD Sharing: NO. Countries: 1. Publications: 0.
Phase II Clofarabine and Cytarabine for Newly Diagnosed Acute Myeloid Leukemia
ClinicalTrials.gov study NCT01960387. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of GDX012 in Adults With Relapsed or Refractory Acute Myeloid Leukemia
ClinicalTrials.gov study NCT05886491. IPD Sharing: YES. Countries: 2. Publications: 0.
Combination of Venetoclax, Hypomethylation Agent and Low-dose Cytarabine as a Salvage Therapy for Acute Myeloid Leukemia
ClinicalTrials.gov study NCT05362942. IPD Sharing: NO. Countries: 0. Publications: 9.
A Study of Venetoclax in Combination With Conventional Chemotherapy in Pediatric Patients With Acute Myeloid Leukemia
ClinicalTrials.gov study NCT05955261. IPD Sharing: YES. Countries: 1. Publications: 0.
Phase 1 Study of SGI-110 in Patients With Acute Myeloid Leukemia
ClinicalTrials.gov study NCT02293993. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Treosulfan and Fludarabine in Treating Younger Patients Who Are Undergoing a Donor Stem Cell Transplant for Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndrome
ClinicalTrials.gov study NCT00253513. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Ixazomib (MLN9708) in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
ClinicalTrials.gov study NCT02030405. IPD Sharing: NO. Countries: 1. Publications: 0.
Safety, Tolerability and Efficacy of the BL-8040 and Atezolizumab for Maintenance Treatment in Subjects With Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT03154827. IPD Sharing: NO. Countries: 6. Publications: 0.
A Study Evaluating the Safety and Pharmacokinetics of Atezolizumab Administered in Combination With Hu5F9-G4 to Patients With Relapsed and/or Refractory Acute Myeloid Leukemia
ClinicalTrials.gov study NCT03922477. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.